Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

New compounds may help treat heart disease by activating specific potassium channels.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Lipid-based delivery systems can improve tissue repair and regeneration when combined with cell-based therapies.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Padina arborescens and its component MOGG may help prevent hair loss through several actions, including blocking a hair loss-related enzyme.

Cationic polymers improved liposome stability and increased skin absorption of aciclovir and minoxidil.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Human platelets change minoxidil to minoxidil sulfate, helping blood vessels widen.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Corticosteroids can reduce scarring in acne keloidalis by targeting specific cells.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.